Drawing for AVIMOTIN

USPTO serial 79068993

AVIMOTIN

Reviewed by CopyMark Law Group

Reg. 3807191Status 404
Filing date
Status date
Registration date
Jun 22, 2010
Examiner
PARADEWELAI, BENJI YUEN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AVIMOTIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Adrienne L. White

Adrienne L. White WRB-IP LLPPO BOX 476Wadsworth, OH 44282UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for the prevention, treatment and diagnosis of diseases, in particular medicines, vaccines, serums and test kits comprised of small molecules, liposomes, aptamers, nucleic acids, peptides, proteins, protein conjugates, antibodies, enzymes and enzyme preparations, hormones, hormone analogues, attenuated viruses, virus-like particles and plant extracts, in particular for oral, topical, intravenous and subcutaneous administration, all for the prevention, treatment and diagnosis of tumour precursors, benign and malignant tumours, in particular warts, genital warts, neurona1 tumours, glioma, astrocytoma, colon carcinoma, ovarian carcinoma, cervical cancer, prostate carcinoma, basa1 cell carcinoma, squamous cell carcinoma, melanoma, Kaposi's sarcoma, breast cancer, head and neck carcinomas, hepatocellular carcinoma, bronchial carcinoma, pancreatic tumours and renal tumours, autoimmune disorders, in particular rheumatoid arthritis, polyarthritis, Crohn's disease, lupus erythematosus and multiple sclerosis, rheumatic disorders, in particular rheumatoid arthritis, polychondritis, Bechterew's disease, fibromyalgia and lupus erythematosus, skin diseases, in particular warts, genital warts, Bowen's disease, actinic keratosis, seborrhoeic keratosis, psoriasis, dermatitis, eczema, acne, rosacea and herpesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 29, 2019DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Nov 29, 2019DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 24, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 20, 2017INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 28, 2017INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 28, 2017INPCINVALIDATION PROCESSED—
Sep 27, 2017INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 27, 2017C71TCANCELLED SECTION 71—
Jun 22, 2015REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 12, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 30, 2010FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 30, 2010FIMPFINAL DISPOSITION PROCESSED—
Sep 22, 2010FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 3, 2010TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 22, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 6, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 6, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 3, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 25, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 23, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 23, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 23, 2010CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 23, 2010ALIEASSIGNED TO LIE—
Jan 25, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 11, 2009RFNTREFUSAL PROCESSED BY IB—
Aug 5, 2009ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 5, 2009REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 24, 2009RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 24, 2009RFRRREFUSAL PROCESSED BY MPU—
Jul 24, 2009RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 23, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 22, 2009DOCKASSIGNED TO EXAMINER—
Jun 30, 2009MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 26, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 25, 2009REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance